Abstract
With the near availability of a cloned Caenorhabditis elegans ORFeome, the development of a high-throughput worm interactome mapping project has now become feasible. After reviewing the increasing interest for C. elegans as a model organism, from ”classical“ biology to the post-genomic era, this article presents the early steps accomplished for the generation of a C. elegans protein interaction map using the twohybrid system. Different approaches have been examined in order to determine the appropriate strategy to screen protein-protein interactions on a large scale. Our version of the two-hybrid system has been used to generate prototype maps for 4 different C. elegans biological modules (vulval development, proteasome, DNA repair / cell cycle and dauer). Those pilot projects helped us developing experimental procedures to avoid most false positive protein interactions while covering a satisfactory proportion of geniune interactions. In silico analysis and experimental validation of the potential protein interactions have already demonstrated biological relevance for some of the networks of interactions obtained.
Keywords: Caenorhabditis elegans orfeome
Current Genomics
Title: The Caenorhabditis elegans Interactome Mapping Project
Volume: 3 Issue: 2
Author(s): Jean-Francois Rual, Philippe Lamesch, Jean Vandenhaute and Marc Vidal
Affiliation:
Keywords: Caenorhabditis elegans orfeome
Abstract: With the near availability of a cloned Caenorhabditis elegans ORFeome, the development of a high-throughput worm interactome mapping project has now become feasible. After reviewing the increasing interest for C. elegans as a model organism, from ”classical“ biology to the post-genomic era, this article presents the early steps accomplished for the generation of a C. elegans protein interaction map using the twohybrid system. Different approaches have been examined in order to determine the appropriate strategy to screen protein-protein interactions on a large scale. Our version of the two-hybrid system has been used to generate prototype maps for 4 different C. elegans biological modules (vulval development, proteasome, DNA repair / cell cycle and dauer). Those pilot projects helped us developing experimental procedures to avoid most false positive protein interactions while covering a satisfactory proportion of geniune interactions. In silico analysis and experimental validation of the potential protein interactions have already demonstrated biological relevance for some of the networks of interactions obtained.
Export Options
About this article
Cite this article as:
Rual Jean-Francois, Lamesch Philippe, Vandenhaute Jean and Vidal Marc, The Caenorhabditis elegans Interactome Mapping Project, Current Genomics 2002; 3 (2) . https://dx.doi.org/10.2174/1389202024605206
DOI https://dx.doi.org/10.2174/1389202024605206 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced AI Techniques in Big Genomic Data Analysis
The thematic issue on "Advanced AI Techniques in Big Genomic Data Analysis" aims to explore the cutting-edge methodologies and applications of artificial intelligence (AI) in the realm of genomic research, where vast amounts of data pose both challenges and opportunities. This issue will cover a broad spectrum of AI-driven strategies, ...read more
Emerging Molecular Mechanisms in Rare Genetic Skeletal Disorders: Linking Genomic Mutations to Clinical Outcomes.
Rare genetic skeletal disorders encompass a diverse group of conditions that impact bone and cartilage development, often due to pathogenic mutations in critical developmental genes. This thematic issue aims to explore the intricate molecular mechanisms underlying these disorders, providing insights into how specific genomic mutations translate into clinical phenotypes. Recent ...read more
Genomic Insights into Oncology: Harnessing Machine Learning for Breakthroughs in Cancer Genomics.
This special issue aims to explore the cutting-edge intersection of genomics and oncology, with a strong emphasis on original data and experimental validation. While maintaining the focus on how machine learning and advanced data analysis techniques are revolutionizing our understanding and treatment of cancer, this issue will prioritize contributions that ...read more
Integrating Artificial Intelligence and Omics Approaches in Complex Diseases
Recent advancements in AI and omics methodologies have revolutionized the landscape of biomedical research, enabling us to extract valuable information from vast amounts of complex data. By combining AI algorithms with omics technologies such as genomics, proteomics, metabolomics, and transcriptomics, researchers can obtain a more comprehensive and multi-dimensional analysis of ...read more
Related Journals

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Mesenchymal Stromal Cells (MSCs): A Promising Tool for Cell-Based Angiogenic Therapy
Current Gene Therapy The Pathobiology of Endothelin-1 in Vein Graft Disease: Are ETA Receptor Antagonists the Solution to Prevent Vein Graft Failure?
Current Vascular Pharmacology Therapeutic Angiogenesis for Limb Ischemia Using Angiogenic Growth Factors and Carriers
Current Tissue Engineering (Discontinued) Alzheimer’s Disease Risk and Progression: The Role of Nutritional Supplements and their Effect on Drug Therapy Outcome
Current Neuropharmacology Viral Anti-Inflammatory Proteins: The Potential for Immunotherapeutic Applications in Cancer
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry “Connecting the Dots” from Blood Brain Barrier Dysfunction to Neuroinflammation and Alzheimer’s Disease
Current Neurovascular Research Recent Advances Using Phosphodiesterase 4 (PDE4) Inhibitors to Treat Inflammatory Disorders: Animal and Clinical Studies
Current Drug Therapy Prognostic Impact of Tissue Inhibitor of Metalloproteinase-1 in Non- Small Cell Lung Cancer: Systematic Review and Meta-Analysis
Current Medicinal Chemistry Radiopharmaceuticals, Drug Development and Pharmaceutical Regulations in Europe
Current Radiopharmaceuticals The Caveolin-1 Connection to Cell Death and Survival
Current Molecular Medicine The Ins and Outs of Nanoparticle Technology in Neurodegenerative Diseases and Cancer
Current Drug Metabolism Brain Perfusion In Sepsis
Current Vascular Pharmacology Polymer Structures for Sensors and Actuators 1. Analyte Biosensor
Recent Patents on Materials Science Liposomal Formulation for Dermal and Transdermal Drug Delivery: Past, Present and Future
Recent Patents on Drug Delivery & Formulation Can Environmentally Relevant Levels of Aluminium Promote the Onset and Progression of Neurodegenerative Diseases?
Current Inorganic Chemistry (Discontinued) Epratuzumab and Blinatumomab as Therapeutic Antibodies for Treatment of Pediatric Acute Lymphoblastic Leukemia: Current Status and Future Perspectives
Current Medicinal Chemistry Lipid Profile of Children Suffering from Pediatric Rheumatic Diseases (pRDS)
Current Rheumatology Reviews Deciphering Role of Cytokines for Therapeutic Strategies Against Rheumatoid Arthritis
Current Drug Targets Focus on the Role of Glutamate in the Pathology of the Peripheral Nervous System
CNS & Neurological Disorders - Drug Targets Studies on Target Genes of General Anesthetics-Version 2
Medicinal Chemistry Reviews - Online (Discontinued)